| Serial Number | 98191847 |
| Word Mark | DAY ONE BIOPHARMACEUTICALS |
| Filing Date | Thursday, September 21, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Friday, January 10, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the words DAY ONE above the word BIOPHARMACEUTICALS with sun rays emanating from and above the "e" at the end of the word ONE. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Providing pharmaceutical information and support services, namely, providing product information and support services regarding the dosing, administration, and clinical profile of the prescription drugs and treatment of diseases; healthcare services, namely, disease management programs; providing medical information regarding the treatment, and diagnosis of diseases; providing medical information regarding pharmaceutical products for the treatment of diseases; providing medical information and advice for healthcare service providers and patients in connection with pharmaceutical product treatment; healthcare services, namely, providing cancer treatment medical information to physicians, health care professionals, and patients; medical information services, namely, providing medical information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing a website featuring health information in the field of tumors and cancer; providing a website featuring health information in the field of pediatric low-grade glioma; providing medical information regarding the treatment and diagnosis of tumors and cancer; providing medical information regarding the treatment and diagnosis of pediatric low-grade glioma; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with tumors and cancer; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with pediatric low-grade glioma; medical information services regarding tumors and cancer, and pediatric low-grade glioma; providing information regarding the treatment, and diagnosis of diseases; providing medical information relating to prescription drugs |
| NOT AVAILABLE | BIOPHARMACEUTICALS |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 9, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Day One Biopharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005 |
| Event Date | Event Description |
| Monday, September 25, 2023 | NEW APPLICATION ENTERED |
| Monday, October 9, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 10, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, February 27, 2024 | ASSIGNED TO EXAMINER |
| Friday, March 8, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, March 8, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, March 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 6, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, June 6, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, September 9, 2024 | DIVISIONAL REQUEST RECEIVED |
| Monday, September 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 9, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, September 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 11, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, October 15, 2024 | DIVISIONAL PROCESSING COMPLETE |
| Friday, January 10, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, January 10, 2025 | FINAL REFUSAL E-MAILED |
| Friday, January 10, 2025 | FINAL REFUSAL WRITTEN |
| Friday, January 10, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, January 10, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, January 10, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |